Search details
1.
Bridging biological cfDNA features and machine learning approaches.
Trends Genet
; 39(4): 285-307, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36792446
2.
Current and future perspectives of liquid biopsies in genomics-driven oncology.
Nat Rev Genet
; 20(2): 71-88, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30410101
3.
Expression of the cancer-associated DNA polymerase ε P286R in fission yeast leads to translesion synthesis polymerase dependent hypermutation and defective DNA replication.
PLoS Genet
; 17(7): e1009526, 2021 07.
Article
in English
| MEDLINE | ID: mdl-34228709
4.
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.
Mol Cancer
; 22(1): 133, 2023 08 12.
Article
in English
| MEDLINE | ID: mdl-37573301
5.
Targeting epigenetic features in clear cell sarcomas based on patient-derived cell lines.
J Transl Med
; 21(1): 54, 2023 01 29.
Article
in English
| MEDLINE | ID: mdl-36710341
6.
Complementary omics strategies to dissect p53 signaling networks under nutrient stress.
Cell Mol Life Sci
; 79(6): 326, 2022 May 30.
Article
in English
| MEDLINE | ID: mdl-35635656
7.
ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform.
Cell Mol Life Sci
; 79(7): 391, 2022 Jul 01.
Article
in English
| MEDLINE | ID: mdl-35776213
8.
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients.
Br J Cancer
; 126(3): 456-463, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34754095
9.
A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study.
Int J Cancer
; 148(6): 1452-1461, 2021 03 15.
Article
in English
| MEDLINE | ID: mdl-32949150
10.
Validation of a next-generation sequencing assay for the detection of EGFR mutations in cell-free circulating tumor DNA.
Exp Mol Pathol
; 123: 104685, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34560086
11.
Novel phenotypes observed in patients with ETV6-linked leukaemia/familial thrombocytopenia syndrome and a biallelic ARID5B risk allele as leukaemogenic cofactor.
J Med Genet
; 57(6): 427-433, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31704777
12.
MUG Mel3 Cell Lines Reflect Heterogeneity in Melanoma and Represent a Robust Model for Melanoma in Pregnancy.
Int J Mol Sci
; 22(21)2021 Oct 20.
Article
in English
| MEDLINE | ID: mdl-34768746
13.
Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows.
Clin Chem
; 66(1): 149-160, 2020 01 01.
Article
in English
| MEDLINE | ID: mdl-31628139
14.
Sensitive and broadly applicable residual disease detection in acute myeloid leukemia using flow cytometry-based leukemic cell enrichment followed by mutational profiling.
Am J Hematol
; 95(10): 1148-1157, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32602117
15.
Single tube liquid biopsy for advanced non-small cell lung cancer.
Int J Cancer
; 144(12): 3127-3137, 2019 06 15.
Article
in English
| MEDLINE | ID: mdl-30536653
16.
Genome-Wide Analysis of the Nucleosome Landscape in Individuals with Coffin-Siris Syndrome.
Cytogenet Genome Res
; 159(1): 1-11, 2019.
Article
in English
| MEDLINE | ID: mdl-31658463
17.
Detection and Characterization of Circulating Tumor Cells in Patients with Merkel Cell Carcinoma.
Clin Chem
; 65(3): 462-472, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30626636
18.
Clinical implications of subclonal TP53 mutations in acute myeloid leukemia.
Haematologica
; 104(3): 516-523, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30309854
19.
G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1.
Int J Cancer
; 142(1): 121-132, 2018 01 01.
Article
in English
| MEDLINE | ID: mdl-28875496
20.
Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide.
Int J Cancer
; 143(5): 1236-1248, 2018 09 01.
Article
in English
| MEDLINE | ID: mdl-29574703